neffy® nasal spray– emergency epi without a needle Artwork

Druggist For The People

Four score and seven minutes ago (about an hour and a half) your physician brought forth, upon her desk, a new prescription, conceived in best medical practice, and dedicated to the proposition that all generics are created equal. Now we are engaged in a great civilian war, testing whether that medication, or any medication so conceived, and so dedicated, can help us long endure. And maybe we can feel good at the same time. For forty years as a pharmacist, I've been building bridges - from the doctor to those in need of important drug information - you. With respect for the listener, and from the perspective that it is better to apply a recommended course of therapy than it is to comply with an ordered course, the goal here is not to provide specific answers about your drug therapy, but rather to help you generate the questions that will that will empower you in this. Toward that end, there will be weekly podcasts, very often with guests who will be "the people".

All Episodes

Druggist For The People

neffy® nasal spray– emergency epi without a needle

August 20, 2024 • Donald Schoeff R.Ph.

Send us a text

Summary: neffy® nasal spray received fast track approval from the FDA on August 9, 2024 for the emergency treatment of type I allergic reactions, including anaphylaxis, in adult and pediatric patients who weight at least 66 pounds. This may be a gamechanger in that it provides emergency epinephrine treatment for anaphylaxis without needles. But, as with all medications, correct use and monitoring is necessary.

Topics

· Fast Track Approval 01:30

· $$$ 03:15

· Minimum Weight 66 pounds 04:15

· Approval Process 06:00

· Pharmacokinetics & Pharmacodynamics 07:00

· Epi Mechanism of Action 08:00

· How to use neffy 10:45

· Storage 13:00

· Gamechanger? 15:00

· risk – BENEFIT 16:20

· Dosing (1/2 Life) 18:25

· Storage 22:15

Questions and comments to druggistforthepeople@gmail.com

People on this episode

Donald J. Schoeff, R.Ph.

Host